Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project
NCT06004674
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Adverse Pregnancy Outcome
Interventions
DRUG:
Lovenox 40mg
Sponsor
Endeavor Health